1. Home
  2. SEER vs AXR Comparison

SEER vs AXR Comparison

Compare SEER & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seer Inc.

SEER

Seer Inc.

N/A

Current Price

$1.56

Market Cap

113.0M

Sector

Health Care

ML Signal

N/A

Logo AMREP Corporation

AXR

AMREP Corporation

N/A

Current Price

$20.93

Market Cap

110.3M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
SEER
AXR
Founded
2017
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Homebuilding
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
113.0M
110.3M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
SEER
AXR
Price
$1.56
$20.93
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $4.00
N/A
AVG Volume (30 Days)
★ 142.8K
4.8K
Earning Date
11-10-2026
12-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 9.40
N/A
EPS
N/A
★ 0.05
Revenue
★ $16,578,000.00
$12,831,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$20.50
$27.27
P/E Ratio
★ N/A
$422.50
Revenue Growth
★ 16.99
N/A
52 Week Low
$1.55
$17.61
52 Week High
$2.38
$29.01

Technical Indicators

Market Signals
Indicator
SEER
AXR
Relative Strength Index (RSI) 27.98 46.80
Support Level N/A $20.33
Resistance Level $1.85 $21.55
Average True Range (ATR) 0.12 0.61
MACD -0.02 0.08
Stochastic Oscillator 5.45 57.39

Price Performance

Historical Comparison
SEER
AXR

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

About AXR AMREP Corporation

Amrep Corp is engaged in real estate business. The company develops both residential lots and sites for commercial and industrial use as demand warrants. It offers for sale both developed and undeveloped real property to its internal homebuilder as well as national, regional, and local homebuilders, commercial and industrial property developers and others. Activities conducted or arranged by the company include land and site planning, obtaining governmental and environmental approvals, installing utilities and storm drains, ensuring the availability of water service, building or improving roads necessary for land development and constructing community amenities. It also provides landscaping services to homebuilders. It operates in two business segments: land development and homebuilding.

Share on Social Networks: